Educational Video Series

K. Scott Baker, MD

Scott Baker

Dr. Baker is a Member in the Clinical Research and Public Health Sciences Divisions at the Fred Hutchinson Cancer Research Center and Professor in the Department of Pediatrics at the University of Washington in Seattle Washington.  He holds the Gloria and Gerald Swanson Endowed Chair for Pediatric Blood and Marrow Transplant Research and is the Director of the Pediatric Blood and Marrow Transplantation and Cancer Survivorship Programs.  He is a nationally recognized expert in the field of hematopoietic stem cell transplantation and in cancer survivorship and late effects.

He received his M.D. degree at the University of Nebraska College of Medicine in 1988, completed his internship and residency in Pediatrics at the University of Nebraska Medical Center in 1991 and subsequently did his post-doctoral fellowship in Hematology-Oncology at The Children's Hospital Medical Center, Cincinnati OH, 1991-1994. Dr, Baker then returned to the University of Nebraska as faculty in Pediatric Hematology-Oncology and Bone Marrow Transplant where he remained until joining the faculty at the University of Minnesota in 1997.  In 2009 he joined the Fred Hutchinson Cancer Research Center and the University of Washington in Seattle Washington. He is board certified in Pediatrics Hematology/Oncology.

Dr. Baker's research interests are in the acute and long term-effects of hematopoietic cell transplantation and are focused on the use of epidemiologic methods to study treatment related acute and long-term complications in survivors after hematopoietic stem cell transplant. This research forms the basis for his current grant support in which the incidence, risk factors, and characteristics of cardiac, pulmonary, renal, endocrine, reproductive late effects and quality of life outcomes in survivors are being studied. Additional studies are examining the “metabolic syndrome” and the early development of cardiovascular risk factors and diabetes in transplant survivors.  Dr. Baker also serves as the principal investigator for several hematopoietic stem cell transplant clinical trials, particularly for treatment of children with hemophagoytic lymphohistiocytosis (HLH), Langerhan’s Cell Histiocytosis (LCH) and other primary immune deficiencies.  For these patients, a novel type of transplantation that is designed to make transplantation for patients with these disorders safer by utilizing a reduced intensity transplant preparative regimen is being investigated.  He has authored over 125 research papers and book chapters, and is a member of numerous professional societies including the Histiocyte Society since 1995 where he has been involved with both the LCH and HLH committees and served on the scientific Review Committee from 2005-2011.



View Dr. Baker's video: Late Effects in Langerhans Cell Histiocytosis (LCH)
Return to Educational Video Series page

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   

¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: Nosotros podremos responderle tan pronto nos sea possible. Gracias!